Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

Background Cervical cancer is 1 of the most common cancers in females worldwide.
Understanding the most recent global patterns and temporal trends of cervical cancer …

Background The investigational 9-valent viruslike particle vaccine against human
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …

Background: This study sought to determine the prevaccine type-specific prevalence of
human papillomavirus (HPV)–associated cancers in the United States to evaluate the …

Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Background Screening programs involve testing asymptomatic individuals with an accurate
screening test to identify those likely to have the disease of interest and to further investigate …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

Breast and cervical cancers are the commonest cancers diagnosed in women living in low-
income and middle-income countries (LMICs), where opportunities for prevention, early …